Nasdaq grants Addentax (ATXG) extra 180 days to fix $1 bid price

Rhea-AI Filing Summary

Addentax Group Corp. reported that Nasdaq has granted it an additional 180 days, until April 6, 2026, to regain compliance with the exchange’s minimum bid price rule. The company had previously fallen below the required $1.00 per share closing bid price for 30 consecutive business days and did not regain compliance by the initial deadline of October 6, 2025, despite its stock trading above $1.00 for ten consecutive days before that date.

Nasdaq’s extension is based on Addentax continuing to meet other Nasdaq Capital Market listing standards and its written plan to cure the deficiency, which may include a reverse stock split. If the closing bid stays at or above $1.00 for at least ten consecutive business days during this second period, Nasdaq staff plan to confirm compliance. If Addentax fails to demonstrate compliance by April 6, 2026, its securities are expected to be delisted, although the company would have the right to appeal.

Positive

• None.

Negative

• Ongoing Nasdaq listing deficiency and delisting risk: Addentax failed to regain compliance with Nasdaq’s $1.00 minimum bid price rule by the initial October 6, 2025 deadline and now faces possible delisting if it cannot cure the deficiency by April 6, 2026, even though it has received an additional 180‑day compliance period.

Insights

Equity & Listing Standards Analyst

Nasdaq gave Addentax more time to fix its sub‑$1 share price, but delisting risk remains if it cannot comply by April 2026.

The company confirms it did not regain full compliance with Nasdaq’s $1.00 minimum bid requirement by the initial October 6, 2025 deadline, even though the stock traded above that level for ten consecutive days beforehand. Nasdaq has therefore used its discretion to grant a second 180‑day cure period ending on April 6, 2026, which is a standard pathway for issuers that meet other listing criteria.

This extension depends on Addentax continuing to satisfy all other Nasdaq Capital Market listing standards, including market value of publicly held shares. The company has told Nasdaq it may use a reverse stock split if needed, a common technical remedy to lift the share price without changing overall market value. If the bid price reaches at least $1.00 for ten consecutive business days during this window, Nasdaq staff intend to confirm compliance; otherwise, they indicate the securities will be delisted, subject to a potential appeal to a hearings panel.

false 0001650101 0001650101 2025-10-07 2025-10-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 7, 2025

Addentax Group Corp.

(Exact name of registrant as specified in its charter)

Nevada		001-41478		35-2521028
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

Kingkey 100, Block A, Room 4805, Luohu District, Shenzhen City, China		518000
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code +(86) 755 86961 405

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock		ATXG		Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

As previously disclosed, Addentax Group Corp. (the “Company” or “our”) received a notice dated April 9, 2025, from the Listings Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share of its common stock, par value $0.001 per share (the “Common Stock”), was below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), Nasdaq granted the Company 180 days, or until October 6, 2025, to regain compliance with the Minimum Bid Price Rule. In order to regain compliance, the closing bid price of the Common Stock must be at least $1 per share for a minimum of 10 consecutive business days during this 180-day period.

Although the Company’s closing bid price had been above the minimum requirement for ten consecutive trading days prior to October 6, 2025, the Nasdaq determined that the Company had not regained compliance with the Minimum Bid Price Rule as of that date.

However, the Staff determined that the Company was eligible for an additional 180-day period, or until April 6, 2026, to regain compliance. The Staff’s determination was based on (i) our meeting the continued listing requirement for market value of our publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the Minimum Bid Price Rule, and (ii) our providing written notice to Nasdaq of our intent to cure the deficiency during this second compliance period, if necessary by effecting a reverse stock split. If at any time during this second 180-day period the closing bid price of the Company’s Common Stock is at least $1 per share for at least a minimum of 10 consecutive business days, the Staff have stated that they will provide written confirmation of compliance. If compliance cannot be demonstrated by April 6, 2026, the Staff will provide written notification that the Company’s securities will be delisted. At that time, the Company may appeal the Staff’s determination to a hearings panel.

The Company is diligently working to regain compliance with the Minimum Bid Price Rule. There can be no assurance, however, of the Company’s ability to maintain compliance with the Minimum Bid Price Rule once compliance therewith is regained or maintain compliance with any other Nasdaq listing requirements.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Addentax Group Corp.
Date: October 7, 2025	By:	/s/ Hong Zhida
		Hong Zhida
		Chief Executive Officer

FAQ

Why did Addentax Group Corp. (ATXG) receive a Nasdaq deficiency notice?

Addentax received a Nasdaq notice because the minimum bid price of its common stock was below $1.00 per share for 30 consecutive business days, failing to meet Nasdaq Listing Rule 5550(a)(2).

How long does Addentax (ATXG) have to regain Nasdaq minimum bid price compliance?

After an initial 180‑day period that ended on October 6, 2025, Nasdaq granted Addentax an additional 180 days, giving the company until April 6, 2026 to regain compliance.

What must Addentax Group Corp. do to regain Nasdaq compliance?

To regain compliance, Addentax’s common stock must have a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days within the applicable compliance period.

Why did Nasdaq grant Addentax a second 180-day compliance period?

Nasdaq granted a second 180‑day period because Addentax met the market value of publicly held shares requirement and all other initial listing standards for the Nasdaq Capital Market, except for the minimum bid price, and provided written notice of its intent to cure the deficiency.

Could Addentax (ATXG) use a reverse stock split to address the bid price issue?

Yes. Addentax informed Nasdaq that it may cure the deficiency during the second compliance period, if necessary by effecting a reverse stock split to raise the per‑share trading price.

What happens if Addentax does not meet Nasdaq’s minimum bid price rule by April 6, 2026?

If Addentax cannot demonstrate compliance by April 6, 2026, Nasdaq staff state they will notify the company that its securities will be delisted, and Addentax would then have the option to appeal that determination to a hearings panel.